Skip to main content
Main Menu
Utility Menu
Search
HARVARD.EDU
GA4 tracking code
Subscribe
Donate
Contact Us
Search
About
Leadership
Faculty
Annual Reports
Contact Us
Research
Disease Programs
Aging & Fibrosis
Stem Cells as Tools
Early-Stage Research
For Patients
Training
Internship Program
MD/PhD Fellowship
Startups
Commercialization
Community
Events
Funding Opportunities
Centers & Cores
Job Opportunities
News
Newsletter Archive
HOME
/
Alexis Borisy, Partner at Third Rock Ventures
Download original image
« Back to gallery
Item 27 of 39
« Previous
|
Next »
“Trying to create a medicine is a wickedly tough thing to do. It takes a village, it takes experience.” Borisy, a venture capitalist and biotechnology entrepreneur at Third Rock Ventures, discussed the role startup companies and investors can play in moving technologies and medicines from the lab to the market. Third Rock Ventures has supported Decibel Therapeutics, Fulcrum Therapeutics, Goldfinch Bio, and Magenta Therapeutics, all of which are founded on science from HSCI Faculty labs.